277
Views
12
CrossRef citations to date
0
Altmetric
Research Article

AAPE proliposomes for topical atopic dermatitis treatment

, , , , , & show all
Pages 768-773 | Received 15 Oct 2013, Accepted 03 Jun 2014, Published online: 04 Aug 2014

References

  • Aschoff R, Schmitt J, Knuschke P, Koch E, Brautigam M, Meurer M. Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography. Exp Dermatol, 2011;20:832–6
  • Boguniewicz M, Leung DY. Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunol Rev, 2011;242:233–46
  • Carr RL. Evaluating flow properties of solids. Chem Eng, 1965;72:163–8
  • Chi EY, Krishnan S, Randolph TW, Carpenter JF. Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation. Pharm Res, 2003;20:1325–36
  • Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, Flavell RA. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA, 2006;103:2274–9
  • Devereux G. The increase in the prevalence of asthma and allergy: Food for thought. Nat Rev Immunol, 2006;6:869–74
  • Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002;99:3838–43
  • Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C, Noel D. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum, 2005;52:1595–603
  • Finch J, Munhutu MN, Whitaker-Worth DL. Atopic dermatitis and nutrition. Clin Dermatol, 2010;28:605–14
  • Fujita H, Meyer N, Akdis M, Akdis CA. Mechanisms of immune tolerance to allergens. Chem Immunol Allergy, 2012;96:30–8
  • Ghajar CM, Kachgal S, Kniazeva E, Mori H, Costes SV, George SC, Putnam AJ. Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms. Exp Cell Res, 2010;316:813–25
  • Groh ME, Maitra B, Szekely E, Koc ON. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol, 2005;33:928–34
  • Gupta V, Barupal AK, Ramteke S. Formulation development and in vitro characterization of proliposomes for topical delivery of aceclofenac. Indian J Pharm Sci, 2008;70:768–75
  • Hanaor D, Michelazzi M, Leonelli C, Sorrell CC. The effects of carboxylic acids on the aqueous dispersion and electrophoretic deposition of ZrO2. J Eur Ceramic Soc, 2012;32:235–44
  • Jiskoot W, Randolph TW, Volkin DB, Middaugh CR, Schoneich C, Winter G, Friess W, Crommelin DJ, Carpenter JF. Protein instability and immunogenicity: Roadblocks to clinical application of injectable protein delivery systems for sustained release. J Pharm Sci, 2012;101:946–54
  • Jukanti R, Sheela S, Bandari S, Veerareddy PR. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery. J Pharm Sci, 2011;100:3208–22
  • Kim WS, Park BS, Kim HK, Park JS, Kim KJ, Choi JS, Chung SJ, Kim DD, Sung JH. Evidence supporting antioxidant action of adipose-derived stem cells: Protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci, 2008;49:133–42
  • Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, de Kleijn DP, Choo A, Lim SK. 2012. Proteolytic potential of the MSC exosome proteome: Implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics 2012:971907
  • Lee JM, Jung J, Lee HJ, Jeong SJ, Cho KJ, Hwang SG, Kim GJ. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol, 2012;13:219–24
  • Leung DY, Bieber T. Atopic dermatitis. Lancet, 2003;361:151–60
  • Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Investig, 2004;113:651–7
  • Liao PF, Sun HL, Lu KH, Lue KH. Prevalence of childhood allergic diseases in central Taiwan over the past 15 years. Pediatr Neonatol, 2009;50:18–25
  • Moon KM, Park Y-H, Lee JS, Chae Y-B, Kim M-M, Kim D-S, Kim B-W, Nam S-W, Lee J-H. The effect of secretory factors of adipose-derived stem cells on human keratinocytes. Int J Mol Sci, 2012;13:1239–57
  • Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A. Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets, 2009;8:110–23
  • Payne NI, Timmins P, Ambrose CV, Ward MD, Ridgway F. Proliposomes: A novel solution to an old problem. J Pharm Sci, 1986;75:325–9
  • Pokharel YR, Lim SC, Kim SC, Heo T-H, Choi HK, Kang KW. Sopungyangjae-tang inhibits development of dermatitis in Nc/Nga mice. Evid Based Complement Altern Med, 2008;5:173–80
  • Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cell Immunol, 2011;270:207–16
  • Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells, 2008;26:212–22
  • Song KH, Chung SJ, Shim CK. Preparation and evaluation of proliposomes containing salmon calcitonin. J Control Rel, 2002;84:27–37
  • Song KH, Chung SJ, Shim CK. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J Control Rel, 2005;106:298–308
  • Stark B, Pabst G, Prassl R. Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure. Eur J Pharm Sci, 2010;41:546–55
  • Tallone T, Realini C, Bohmler A, Kornfeld C, Vassalli G, Moccetti T, Bardelli S, Soldati G. Adult human adipose tissue contains several types of multipotent cells. J Cardiovasc Transl Res, 2011;4:200–10
  • Traidl C, Jugert F, Krieg T, Merk H, Hunzelmann N. Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J Investig Dermatol, 1999;112:476–82
  • Vanoirbeek JA, Tarkowski M, Vanhooren HM, De Vooght V, Nemery B, Hoet PH. Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and |dinitrochlorobenzene, a dermal sensitizer. J Allergy Clin Immunol, 2006;117:1090–7
  • Varshosaz J, Eskandari S, Tabakhian M. Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design. Pharm Dev Technol, 2009;15(1):89–96
  • Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm, 1999;185:129–88
  • Watson W, Kapur S. Atopic dermatitis. Allergy Asthma Clin Immunol, 2011;7(Suppl 1):S4
  • Yang T, Choi MK, Cui FD, Kim JS, Chung SJ, Shim CK, Kim DD. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Control Release, 2007;120:169–77

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.